Low-risk HLA genotype in Type 1 diabetes is associated with less destruction of pancreatic B-cells 12 months after diagnosis. (Q51460655)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17971177%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

title

Low-risk HLA genotype in Type 1 diabetes is associated with less destruction of pancreatic B-cells 12 months after diagnosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17971177%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

0 references

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17971177%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Dario Tuccinardi

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17971177%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

author name string

M Spoletini

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17971177%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

A Petrone

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17971177%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

S Zampetti

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17971177%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

M Capizzi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17971177%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

S Zavarella

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17971177%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

J Osborn

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17971177%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

C Foffi

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17971177%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

P Pozzilli

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17971177%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

IMDIAB Group

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17971177%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

publication date

29 October 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17971177%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17971177%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17971177%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17971177%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

page(s)

1487-1490

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17971177%20AND%20SRC:MED&resulttype=core&format=json

Metabolic and immune parameters at clinical onset of insulin-dependent diabetes: a population-based study. IMDIAB Study Group. Immunotherapy Diabetes.

9 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02292.X

Relationships among islet cell antibodies, residual beta-cell function, and metabolic control in patients with insulin-dependent diabetes mellitus of long duration: use of a sensitive C-peptide radioimmunoassay.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02292.X

Islet antibodies and remaining beta-cell function 8 years after diagnosis of diabetes in young adults: a prospective follow-up of the nationwide Diabetes Incidence Study in Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02292.X

A linkage study of 12 IDDM susceptibility loci in the Finnish population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02292.X

Residual insulin secretion at diagnosis of type 1 diabetes is independently associated with both, age of onset and HLA genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02292.X

Environmental risk factors for type 1 diabetes in Rome and province

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02292.X

C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, 21-22 October 2001.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02292.X

Genetic prediction of type 1 diabetes in a population with low frequency of HLA risk genotypes and low incidence of the disease (the DIABFIN study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02292.X

Decreased expression of pigment epithelium-derived factor is involved in the pathogenesis of diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02292.X

Residual insulin secretion is not coupled to a maintained glucagon response to hypoglycaemia in long-term type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02292.X

Oral insulin administration and residual beta-cell function in recent-onset type 1 diabetes: a multicentre randomised controlled trial. Diabète Insuline Orale group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02292.X

10.1111/J.1464-5491.2007.02292.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17971177%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference